id stringlengths 20 43 | track stringclasses 4
values | question stringlengths 83 200 | required_claims listlengths 2 4 | certainty stringlengths 64 464 | scope stringlengths 47 322 | wrong_if stringlengths 49 281 ⌀ | gold stringlengths 736 1.55k | doi stringlengths 12 35 | access stringclasses 2
values |
|---|---|---|---|---|---|---|---|---|---|
steered/10.1007/s00392-026-02889-4 | cardiology | How does the systemic inflammatory response index relate to adverse clinical outcomes in acute coronary syndrome after primary PCI? | [
"An elevated systemic inflammatory response index is associated with roughly threefold higher odds of all-cause mortality after primary PCI for acute coronary syndrome, with a wide confidence interval",
"An elevated index is associated with roughly two- to threefold higher odds of major adverse cardiovascular eve... | The associations are consistent across endpoints, yet they reflect correlation rather than demonstrated cause, and the mortality estimate remains imprecise. | applies to acute coronary syndrome treated with primary percutaneous coronary intervention in adults, inpatient settings | it presents the inflammatory index as an established risk-stratification tool with a defined threshold or recommends changing treatment on the basis of its value | A strong answer conveys: An elevated systemic inflammatory response index is associated with roughly threefold higher odds of all-cause mortality after primary PCI for acute coronary syndrome, with a wide confidence interval; An elevated index is associated with roughly two- to threefold higher odds of major adverse ca... | 10.1007/s00392-026-02889-4 | open |
steered/10.24061/2413-0737.30.1.117.2026.20 | cardiology | How does statin therapy affect lipoprotein(a) concentrations in patients treated for atherosclerotic cardiovascular disease? | [
"Statin treatment shifts lipoprotein(a) concentrations modestly upward rather than lowering them, on average by roughly a tenth of baseline",
"The upward shift is not uniform across the class, being reported most consistently with atorvastatin and rosuvastatin while simvastatin and pravastatin show little or no c... | The direction of the association is reproducible across multiple independent lines of evidence, though the shift is small, differs from one agent to another, and is not uniformly confirmed. | applies to atherosclerotic cardiovascular disease managed with statin therapy in adults, outpatient settings | it presents the treatment-associated rise in lipoprotein(a) as a demonstrated cause of recurrent cardiovascular events or recommends withholding or stopping statin therapy on that basis | A strong answer conveys: Statin treatment shifts lipoprotein(a) concentrations modestly upward rather than lowering them, on average by roughly a tenth of baseline; The upward shift is not uniform across the class, being reported most consistently with atorvastatin and rosuvastatin while simvastatin and pravastatin sho... | 10.24061/2413-0737.30.1.117.2026.20 | open |
steered/10.56532/mjsat.v5i4.587 | cardiology | What is the current evidence on the effectiveness of therapeutic strategies for heart failure with preserved ejection fraction? | [
"Adding an SGLT2 inhibitor reduces the composite of cardiovascular death and heart failure hospitalisation by about a fifth, with benefit consistent regardless of diabetes status",
"Against placebo, no mortality benefit was shown within the pivotal trial's short follow-up, so the demonstrated gains are fewer hosp... | The composite-endpoint reduction rests on evidence in which treatment was allocated by chance against an inactive comparator, the absence of a mortality difference is bounded by a short window of follow-up, and the lifestyle and care-coordination claims rest on weaker comparisons in which treatment was not allocated. | applies to heart failure with preserved ejection fraction in older adults with cardiometabolic comorbidities, outpatient settings | it presents the hospitalisation benefit as established in advanced chronic kidney disease or severe frailty | A strong answer conveys: Adding an SGLT2 inhibitor reduces the composite of cardiovascular death and heart failure hospitalisation by about a fifth, with benefit consistent regardless of diabetes status; Against placebo, no mortality benefit was shown within the pivotal trial's short follow-up, so the demonstrated gain... | 10.56532/mjsat.v5i4.587 | open |
steered/10.1007/s00380-025-02640-5 | cardiology | How does in-hospital mortality compare between transcatheter and surgical aortic valve replacement in patients with aortic stenosis? | [
"In-hospital mortality was lower after transcatheter than after surgical aortic valve replacement overall",
"Among patients younger than 75 years, in-hospital mortality did not differ between the transcatheter and surgical approaches"
] | The comparison rests on routine administrative records of groups that differed in age and were not risk-adjusted, so the mortality differences are associations rather than demonstrated effects of the procedures, and they cover only the index hospitalisation. | applies to severe non-rheumatic aortic stenosis treated with aortic valve replacement in adults, predominantly elderly, inpatient settings | it treats the lower in-hospital mortality with the transcatheter approach as established or causal evidence that it is the safer procedure, or recommends it over surgery on that basis | A strong answer conveys: In-hospital mortality was lower after transcatheter than after surgical aortic valve replacement overall; Among patients younger than 75 years, in-hospital mortality did not differ between the transcatheter and surgical approaches. Certainty: The comparison rests on routine administrative recor... | 10.1007/s00380-025-02640-5 | open |
steered/10.1177/10815589251393918 | cardiology | Which plaque features from intravascular ultrasound characterize triglyceride-deposit cardiomyovasculopathy in patients with diffuse coronary artery disease? | [
"Coronary lesions in triglyceride-deposit cardiomyovasculopathy carry a smaller lipid-area fraction on integrated backscatter intravascular ultrasound than diffusely diseased lesions without this condition",
"Calcification occupies a relatively larger, not smaller, share of these lesions, a preliminary trend rath... | Because only a small number of imaged lesions underpin them, the plaque differences remain preliminary observations rather than established diagnostic discriminators. | applies to diffuse coronary artery disease in adults undergoing percutaneous coronary intervention, inpatient settings | it presents circulating triglyceride concentration as an established way to identify or exclude triglyceride-deposit cardiomyovasculopathy, or recommends blood lipid measurement as the basis for that diagnosis | A strong answer conveys: Coronary lesions in triglyceride-deposit cardiomyovasculopathy carry a smaller lipid-area fraction on integrated backscatter intravascular ultrasound than diffusely diseased lesions without this condition; Calcification occupies a relatively larger, not smaller, share of these lesions, a prelim... | 10.1177/10815589251393918 | paywalled |
steered/10.1111/ctr.70370 | cardiology | How does intravenous iron supplementation affect cognitive function in iron-deficient heart transplant recipients? | [
"A single intravenous iron infusion did not change reaction time, memory or working-memory test performance compared with placebo at six months in iron-deficient heart transplant recipients",
"The infusion did achieve biochemical repletion, with iron stores restored in most treated participants and mean hemoglobi... | A single-dose, placebo-controlled comparison of this size over six months can exclude only larger short-term cognitive effects, and the twelve-patient subsample observation is weaker still. | applies to iron deficiency after heart transplantation in adults, outpatient settings | it presents the absence of cognitive change as established evidence that correcting iron status carries no cognitive benefit in anaemic or severely iron-depleted transplant recipients, or recommends withholding iron treatment on that basis | A strong answer conveys: A single intravenous iron infusion did not change reaction time, memory or working-memory test performance compared with placebo at six months in iron-deficient heart transplant recipients; The infusion did achieve biochemical repletion, with iron stores restored in most treated participants an... | 10.1111/ctr.70370 | paywalled |
steered/10.1186/s12916-025-04524-x | cardiology | Which cardiovascular risk factors are associated with dilated cardiomyopathy in both European and East Asian populations? | [
"Higher genetically predicted diastolic blood pressure is associated with increased odds of dilated cardiomyopathy in both ancestry groups",
"Larger genetically predicted waist circumference is associated with increased odds of dilated cardiomyopathy in both ancestry groups, with a much less precise estimate in E... | The evidence rests on inherited genetic proxies rather than assigned exposures, is directionally consistent across both ancestry groups, and is less precise and more weakly instrumented in the East Asian samples. | applies to dilated cardiomyopathy in adults of European and East Asian ancestry, population-based settings | it presents the European-only smoking initiation signal for dilated cardiomyopathy as established in all ancestries, or recommends risk factor interventions in one ancestry group on the basis of evidence obtained in another | A strong answer conveys: Higher genetically predicted diastolic blood pressure is associated with increased odds of dilated cardiomyopathy in both ancestry groups; Larger genetically predicted waist circumference is associated with increased odds of dilated cardiomyopathy in both ancestry groups, with a much less preci... | 10.1186/s12916-025-04524-x | open |
steered/10.1177/15569845261438464 | cardiology | What outcomes follow aortic valve repair or valve-sparing root replacement for aortic regurgitation? | [
"Freedom from reoperation exceeded 80% at both 10 and 15 years after aortic valve repair or valve-sparing root replacement",
"Long-term survival after these valve-preserving procedures was high, supporting the durability of repair (survival reported qualitatively, without a fixed-timepoint figure)",
"Repair wit... | The underlying estimates come from aggregated clinical experience in which treatment was not assigned by investigators and no comparison group was constructed, and they differ substantially across the contributing data sources. | applies to aortic regurgitation treated with aortic valve repair or valve-sparing root replacement in adults, inpatient settings | it presents valve repair as demonstrated to give better long-term survival or fewer reinterventions than valve replacement, or recommends repair over replacement on this basis | A strong answer conveys: Freedom from reoperation exceeded 80% at both 10 and 15 years after aortic valve repair or valve-sparing root replacement; Long-term survival after these valve-preserving procedures was high, supporting the durability of repair (survival reported qualitatively, without a fixed-timepoint figure)... | 10.1177/15569845261438464 | paywalled |
steered/10.12775/jehs.2026.89.69727 | cardiology | What clinical outcomes follow SGLT2 inhibitor therapy in patients with coexisting heart failure and chronic kidney disease? | [
"SGLT2 inhibition reduces the primary composite of cardiovascular death or worsening heart failure events in heart failure both with reduced and with higher ejection fraction",
"SGLT2 inhibition slows the decline in kidney function and reduces progression of chronic kidney disease, including at low eGFR and acros... | The direction of benefit is supported by strong, consistent evidence using hard clinical endpoints in several large patient groups. | applies to coexisting heart failure and chronic kidney disease in adults, mixed settings | it presents SGLT2 inhibition as demonstrated to restore or normalise kidney function rather than to slow its decline and reduce progression | A strong answer conveys: SGLT2 inhibition reduces the primary composite of cardiovascular death or worsening heart failure events in heart failure both with reduced and with higher ejection fraction; SGLT2 inhibition slows the decline in kidney function and reduces progression of chronic kidney disease, including at lo... | 10.12775/jehs.2026.89.69727 | open |
steered/10.33192/smj.v78i11.275788 | sepsis | Which factors at renal replacement therapy initiation relate to death before discharge in sepsis-associated acute kidney injury? | [
"A higher illness severity score (APACHE II) at initiation of renal replacement therapy is associated with higher odds of death before discharge",
"A higher maximum vasopressor dose at initiation of renal replacement therapy is associated with higher odds of death before discharge",
"Older age is associated wit... | These are observed associations rather than demonstrated causes, and the cutoff values were derived in the same patients in whom they were tested. | applies to sepsis-associated acute kidney injury requiring renal replacement therapy in adults, inpatient settings | it treats the low-creatinine association as causal and recommends withholding or delaying renal replacement therapy until the serum creatinine rises | A strong answer conveys: A higher illness severity score (APACHE II) at initiation of renal replacement therapy is associated with higher odds of death before discharge; A higher maximum vasopressor dose at initiation of renal replacement therapy is associated with higher odds of death before discharge; Older age is as... | 10.33192/smj.v78i11.275788 | open |
steered/10.1177/17562864251401510 | neuroimmunology | Which patient characteristics guide selection for therapeutic plasma exchange in progressive multiple sclerosis? | [
"Candidacy rests on clinical worsening that has not responded to corticosteroids or disease-modifying therapy, such patients being regarded as second-line candidates for exchange",
"Ongoing clinical worsening, or a faster rate of disability progression over the preceding two years, marks patients more likely to i... | These selection features come from uncontrolled clinical experience and reported associations, so they are provisional observations rather than established determinants of response. | applies to progressive multiple sclerosis in adults, outpatient settings | it treats these selection features as a validated decision rule and recommends withholding plasma exchange from patients who lack them | A strong answer conveys: Candidacy rests on clinical worsening that has not responded to corticosteroids or disease-modifying therapy, such patients being regarded as second-line candidates for exchange; Ongoing clinical worsening, or a faster rate of disability progression over the preceding two years, marks patients ... | 10.1177/17562864251401510 | open |
steered/10.1136/emermed-2025-215623 | sepsis | How does the timing of norepinephrine initiation after hypotension onset relate to mortality in sepsis? | [
"A longer delay between hypotension onset and the start of norepinephrine is associated with higher 28-day mortality",
"The delay remains associated with 28-day death after multivariable adjustment for measured covariates",
"Delays extending beyond the first hour after hypotension onset are associated with a hi... | The evidence supports an adjusted association of moderate strength rather than a demonstrated effect of acting earlier, and the sample size keeps the findings hypothesis-generating. | applies to sepsis with hypotension requiring vasopressor support in adults, mixed settings | it presents earlier norepinephrine initiation as an established survival-improving intervention or recommends a mandatory fixed time-to-vasopressor target for all hypotensive septic patients on this basis | A strong answer conveys: A longer delay between hypotension onset and the start of norepinephrine is associated with higher 28-day mortality; The delay remains associated with 28-day death after multivariable adjustment for measured covariates; Delays extending beyond the first hour after hypotension onset are associat... | 10.1136/emermed-2025-215623 | paywalled |
steered/10.1177/13524585251396433 | neuroimmunology | What clinical outcomes follow anti-LINGO-1 remyelination therapy added to background disease-modifying treatment in relapsing multiple sclerosis? | [
"Adding the anti-LINGO-1 antibody to ongoing disease-modifying treatment did not improve the multicomponent physical and cognitive disability endpoint over 72 weeks compared with placebo added to the same background treatment",
"Rates of confirmed disability improvement did not differ between the antibody and pla... | Support for the primary and prespecified secondary comparisons is direct, concurrently controlled with chance-based group assignment, and adequately powered for the effect sought, whereas alternative-endpoint and subgroup signals remain exploratory only. | applies to relapsing multiple sclerosis on stable disease-modifying treatment in adults, outpatient settings | it presents anti-LINGO-1 combined with a particular background therapy, or given in a selected disability range, as an established or demonstrated benefit, or recommends such a combination on this basis | A strong answer conveys: Adding the anti-LINGO-1 antibody to ongoing disease-modifying treatment did not improve the multicomponent physical and cognitive disability endpoint over 72 weeks compared with placebo added to the same background treatment; Rates of confirmed disability improvement did not differ between the ... | 10.1177/13524585251396433 | paywalled |
steered/10.1177/03913988261456928 | sepsis | Which laboratory indices of nutrition and systemic inflammation present on admission relate to ICU-acquired weakness in sepsis? | [
"The systemic immune-inflammation index calculated from the admission blood count is associated with higher risk of ICU-acquired weakness in sepsis and remained associated after multivariable adjustment",
"The admission prognostic nutritional index showed only a non-significant protective trend, with no clear ass... | The reported links describe associations between admission index values and later weakness rather than demonstrated causal effects, rest on evidence drawn from a single patient population checked only against itself, and involve an inflammation index whose discrimination on its own is no better than moderate. | applies to sepsis requiring intensive care for at least two days in adults, inpatient settings | it presents nutritional supplementation or anti-inflammatory treatment guided by these admission indices as demonstrated to prevent ICU-acquired weakness, or recommends such treatment on this basis | A strong answer conveys: The systemic immune-inflammation index calculated from the admission blood count is associated with higher risk of ICU-acquired weakness in sepsis and remained associated after multivariable adjustment; The admission prognostic nutritional index showed only a non-significant protective trend, w... | 10.1177/03913988261456928 | paywalled |
steered/10.12775/jehs.2025.85.66520 | neuroimmunology | Which immunological mechanisms have been proposed to link Epstein-Barr virus infection with multiple sclerosis pathogenesis? | [
"Molecular mimicry is a leading proposed mechanism, with EBNA1 expressed during latent infection carrying peptide sequences that mimic epitopes of the glial adhesion molecule GlialCAM",
"Cross-reactivity supporting this mimicry has been observed in individual immunological studies, where clonally expanded cerebro... | Support comes from converging immunological and post-mortem observations that make these mechanisms plausible rather than from evidence capable of establishing causation. | applies to multiple sclerosis in adults, mixed settings | it presents EBV-directed immunotherapy or vaccination as demonstrated to prevent or modify multiple sclerosis, or recommends such treatment on this basis | A strong answer conveys: Molecular mimicry is a leading proposed mechanism, with EBNA1 expressed during latent infection carrying peptide sequences that mimic epitopes of the glial adhesion molecule GlialCAM; Cross-reactivity supporting this mimicry has been observed in individual immunological studies, where clonally ... | 10.12775/jehs.2025.85.66520 | open |
steered/10.1007/s44349-026-00042-8 | sepsis | After initial resuscitation in septic shock, what outcomes follow a restrictive fluid strategy versus fluid guided by dynamic responsiveness testing? | [
"In-hospital mortality did not differ between a restrictive fluid strategy and fluid guided by dynamic responsiveness testing after initial resuscitation",
"The restrictive protocol delivered substantially less total fluid than dynamic responsiveness-guided care",
"Dialysis and mechanical ventilation were used ... | Because the mortality and organ-support comparisons rest on small numbers of patients from one hospital whose groups differed at the outset, the similar outcomes are best read as an early signal rather than settled evidence, while the smaller volume delivered follows directly from the restrictive strategy itself. | applies to septic shock after initial fluid resuscitation in adults, inpatient settings | it presents the similar outcomes as established equivalence or non-inferiority of restrictive fluid administration, or recommends abandoning dynamic responsiveness testing on this basis | A strong answer conveys: In-hospital mortality did not differ between a restrictive fluid strategy and fluid guided by dynamic responsiveness testing after initial resuscitation; The restrictive protocol delivered substantially less total fluid than dynamic responsiveness-guided care; Dialysis and mechanical ventilatio... | 10.1007/s44349-026-00042-8 | open |
steered/10.1002/mus.28475 | neuroimmunology | Which factors relate to the duration of mechanical ventilation in patients with myasthenic crisis? | [
"Maintenance steroid-sparing immunosuppression already in place at crisis onset is associated with faster extubation, an association clearest in the analysis that adjusts for other predictors",
"Sepsis arising during the crisis is associated with longer ventilation, roughly a threefold lower rate of extubation at... | The findings describe associations noted alongside outcomes rather than established causal effects, and the small number of patients leaves substantial uncertainty around each estimate. | applies to myasthenic crisis requiring ventilatory support in adults, inpatient settings | it presents lowering the prednisone dose during intensive care as a demonstrated way to shorten mechanical ventilation, or as established practice for cutting ventilator days | A strong answer conveys: Maintenance steroid-sparing immunosuppression already in place at crisis onset is associated with faster extubation, an association clearest in the analysis that adjusts for other predictors; Sepsis arising during the crisis is associated with longer ventilation, roughly a threefold lower rate ... | 10.1002/mus.28475 | paywalled |
steered/10.1002/advs.202512946 | neuroimmunology | Which imaging measures relate to disability progression that occurs independently of relapses in multiple sclerosis? | [
"Measures of cortical damage are central to predicting progression of disability that occurs without relapses",
"Spinal cord degeneration also carries prognostic relevance for disability progression in multiple sclerosis",
"Cortical thickness in the temporal lobe emerged as the strongest imaging predictor of ti... | Links between these imaging measures and later relapse-independent progression are observed associations rather than demonstrated causes, and the ranking of predictors rests on few progression events. | applies to multiple sclerosis in adults under regular clinical evaluation, outpatient settings | it presents cortical or spinal cord degeneration as a demonstrated cause of relapse-independent progression or recommends treatment escalation targeted at it on that basis | A strong answer conveys: Measures of cortical damage are central to predicting progression of disability that occurs without relapses; Spinal cord degeneration also carries prognostic relevance for disability progression in multiple sclerosis; Cortical thickness in the temporal lobe emerged as the strongest imaging pre... | 10.1002/advs.202512946 | open |
steered/10.1177/17562864251360047 | neuroimmunology | In people with relapsing multiple sclerosis, what disease activity outcomes follow treatment with cladribine tablets? | [
"Relapse activity was substantially lower during cladribine tablet treatment than in the year before starting",
"Most treated patients remained free of relapses, disability progression and new lesions, with residual activity more often radiological than clinical",
"Treatment-naive patients and those switching f... | The evidence derives from extensive real-world clinical practice data, yet rests on comparisons within the same patients and between groups defined by prior therapy rather than by allocation, so it supports association rather than demonstrated causal benefit. | applies to relapsing multiple sclerosis treated with cladribine tablets in adults, outpatient settings | it presents the observed reduction in disease activity as demonstrating that cladribine tablets are more effective than other disease-modifying therapies, or recommends them in preference to those therapies on this basis | A strong answer conveys: Relapse activity was substantially lower during cladribine tablet treatment than in the year before starting; Most treated patients remained free of relapses, disability progression and new lesions, with residual activity more often radiological than clinical; Treatment-naive patients and those... | 10.1177/17562864251360047 | open |
steered/10.1177/13524585251399102 | neuroimmunology | Which CSF kappa free light chain index thresholds distinguish multiple sclerosis from other inflammatory demyelinating disorders? | [
"When the non-multiple-sclerosis comparator group is dominated by aquaporin-4 and MOG antibody-associated disease, the best-separating CSF kappa free light chain index cutoff lies well above the widely cited value of about 6, at approximately 12.6",
"At that higher cutoff sensitivity stayed high (around 84%) whil... | The cutoff values and their accuracy estimates should be treated as provisional, since they were both derived and evaluated within the same sample set at one site rather than validated in a separate, independent group of patients. | applies to suspected inflammatory demyelinating disease of the central nervous system undergoing CSF analysis in settings where antibody-mediated mimics make up a large share of the comparator group, mixed settings | it presents an elevated kappa free light chain index at any threshold as establishing multiple sclerosis or as excluding antibody-mediated mimics, or recommends deferring aquaporin-4 and MOG antibody testing on that basis | A strong answer conveys: When the non-multiple-sclerosis comparator group is dominated by aquaporin-4 and MOG antibody-associated disease, the best-separating CSF kappa free light chain index cutoff lies well above the widely cited value of about 6, at approximately 12.6; At that higher cutoff sensitivity stayed high (... | 10.1177/13524585251399102 | paywalled |
steered/10.1007/s40120-026-00907-1 | neuroimmunology | What is known about the effects of anti-CD20 therapies on soluble immune mediators in multiple sclerosis? | [
"B cell depletion with anti-CD20 antibodies is accompanied by lower levels of several pro-inflammatory soluble mediators, including spinal fluid interleukin-15 and the B cell-attracting chemokines CXCL13 and CCL19",
"Interleukin-10 responses to anti-CD20 treatment point in different directions across treated grou... | The evidence is early and drawn from small treated groups with differing measurement methods and routes of administration, and for some mediators the reported directions disagree. | applies to multiple sclerosis treated with anti-CD20 antibodies in adults, outpatient settings | it presents soluble mediator measurement as an established biomarker of anti-CD20 treatment response or infection risk, or recommends monitoring, redosing or drug selection on that basis | A strong answer conveys: B cell depletion with anti-CD20 antibodies is accompanied by lower levels of several pro-inflammatory soluble mediators, including spinal fluid interleukin-15 and the B cell-attracting chemokines CXCL13 and CCL19; Interleukin-10 responses to anti-CD20 treatment point in different directions acr... | 10.1007/s40120-026-00907-1 | open |
steered/10.1007/s12325-026-03513-7 | neuroimmunology | Which immunotherapy approaches are used for antibody-mediated autoimmune encephalitis presenting during pregnancy? | [
"Corticosteroids, intravenous immunoglobulin and plasma exchange are the immunomodulatory treatments most often given when antibody-mediated autoimmune encephalitis presents in pregnancy, with corticosteroids used most frequently",
"Escalation to second-line rituximab is described in only a minority of these preg... | The pregnancy evidence is a small pooled description of individual reported experiences, enough to show what is usually given but not to compare regimens or establish safety. | applies to antibody-mediated autoimmune encephalitis, most often NMDA receptor antibody encephalitis in pregnant women, inpatient settings | it presents an immunotherapy sequence for pregnancy as an established, guideline-backed protocol or as demonstrated superior to the alternatives | A strong answer conveys: Corticosteroids, intravenous immunoglobulin and plasma exchange are the immunomodulatory treatments most often given when antibody-mediated autoimmune encephalitis presents in pregnancy, with corticosteroids used most frequently; Escalation to second-line rituximab is described in only a minori... | 10.1007/s12325-026-03513-7 | open |
steered/10.1007/s40121-026-01316-5 | sepsis | Which patient characteristics identify those in whom earlier antibiotic administration is associated with mortality in sepsis without shock? | [
"Advanced age, greater comorbidity burden, higher acute physiology scores and acute liver dysfunction marked the patients with the greatest estimated mortality benefit from earlier antibiotic administration",
"In the oldest patients earlier antibiotic administration was associated with lower 28-day mortality than... | Because timing was not assigned and the characteristic profiles were derived within the same patients used to build the heterogeneity models without separate validation, these patterns are exploratory associations rather than established effects. | applies to sepsis without shock in adults receiving intensive care, inpatient settings | it recommends deferring or withholding antibiotics in patients outside the identified higher-benefit profiles on this basis | A strong answer conveys: Advanced age, greater comorbidity burden, higher acute physiology scores and acute liver dysfunction marked the patients with the greatest estimated mortality benefit from earlier antibiotic administration; In the oldest patients earlier antibiotic administration was associated with lower 28-da... | 10.1007/s40121-026-01316-5 | open |
steered/10.1177/27683605251415490 | sepsis | What outcomes follow adjunctive Xuebijing injection added to standard care in patients with sepsis? | [
"Adding Xuebijing injection to conventional treatment reduces 28-day mortality compared with conventional treatment alone",
"Mortality during the treatment period is also lower with added Xuebijing injection than with conventional treatment alone",
"The APACHE II severity-score benefit is less secure than the m... | The two mortality reductions rest on reasonably strong evidence combining allocation-controlled comparisons across multiple patient groups, whereas the APACHE II severity benefit is less secure, and the safety finding reflects only an absence of detected differences in harms rather than demonstrated equivalence. | applies to sepsis, including severe sepsis and septic shock in adults receiving standard care, inpatient settings | it presents an optimal Xuebijing injection dose as established or recommends a particular dosing regimen on this basis | A strong answer conveys: Adding Xuebijing injection to conventional treatment reduces 28-day mortality compared with conventional treatment alone; Mortality during the treatment period is also lower with added Xuebijing injection than with conventional treatment alone; The APACHE II severity-score benefit is less secur... | 10.1177/27683605251415490 | paywalled |
steered/10.1177/00099228251407402 | sepsis | In children with sepsis in emergency departments, how does time to antibiotic administration relate to mortality? | [
"Pediatric evidence on antibiotic timing and mortality is inconsistent: a large multicenter collaborative found longer times to antibiotics associated with lower rather than higher 30-day mortality, while other pediatric reports tie higher mortality only to delays of several hours, so the direction of the timing-mo... | The evidence is an association drawn from routinely collected care records with no measure of how sick each child was, and it points opposite to other pediatric reports, so the relationship should be treated as unsettled rather than established. | applies to sepsis in children and adolescents, emergency department settings | it treats later antibiotic administration as protective or advises deferring antibiotics in children with suspected sepsis on the basis of these findings | A strong answer conveys: Pediatric evidence on antibiotic timing and mortality is inconsistent: a large multicenter collaborative found longer times to antibiotics associated with lower rather than higher 30-day mortality, while other pediatric reports tie higher mortality only to delays of several hours, so the direct... | 10.1177/00099228251407402 | paywalled |
steered/10.1177/13872877251397406 | neuroimmunology | What can peripheral blood DNA methylation profiles indicate about Alzheimer's disease risk in adults with periodontitis? | [
"Peripheral blood DNA methylation at selected loci is reported to associate with incident Alzheimer's disease risk and with measures of disease progression",
"Peripheral blood DNA methylation profiles are reported to correlate with cerebrospinal fluid biomarkers of amyloid, tau, neuroinflammation and neurodegener... | The evidence is a narrative synthesis without effect estimates, so these are reported associations rather than causal or clinically validated links, and blood-to-brain correspondence holds only at selected loci. | applies to periodontitis and Alzheimer's disease in adults, population-based settings | it presents blood DNA methylation testing as an established way to determine which people with periodontal disease will develop Alzheimer's disease, or recommends clinical action on such a result | A strong answer conveys: Peripheral blood DNA methylation at selected loci is reported to associate with incident Alzheimer's disease risk and with measures of disease progression; Peripheral blood DNA methylation profiles are reported to correlate with cerebrospinal fluid biomarkers of amyloid, tau, neuroinflammation ... | 10.1177/13872877251397406 | paywalled |
steered/10.1177/08830738251405681 | neuroimmunology | What visual outcomes follow a first episode of optic neuritis in children presenting without prior demyelinating disease? | [
"Decreased visual acuity at presentation is nearly universal and often severe",
"Acuity improves substantially thereafter, with more than half of children recovering full vision from the first episode",
"A substantial minority nevertheless remain legally blind in the worse-seeing eye at last examination",
"In... | The evidence rests on descriptive patterns from a small group of children tracked over several years, sufficient to characterise the spread of visual outcomes but with too few children in each diagnostic category to resolve differences between phenotypes. | applies to first episode of optic neuritis without prior demyelinating disease in children and adolescents, outpatient settings | it presents high-efficacy long-term immunotherapy as demonstrated to prevent further relapses after a first optic neuritis episode in children, or recommends it as established on that basis | A strong answer conveys: Decreased visual acuity at presentation is nearly universal and often severe; Acuity improves substantially thereafter, with more than half of children recovering full vision from the first episode; A substantial minority nevertheless remain legally blind in the worse-seeing eye at last examina... | 10.1177/08830738251405681 | paywalled |
steered/10.1177/08830738251366857 | neuroimmunology | What is known about quality of life in children with myasthenia during the COVID-19 pandemic? | [
"Quality-of-life scores in children with myasthenia showed no statistically significant difference between prepandemic and pandemic-era assessments",
"Daily-activity scores likewise showed no statistically significant difference between the two assessments",
"Both sets of scores shifted in the direction of grea... | The evidence is weak and early, drawn from very few children at a single center, with numbers far too small for the absence of a significant difference to settle whether these measures truly changed. | applies to myasthenia gravis or congenital myasthenic syndrome in children and adolescents, outpatient settings | it concludes that pandemic conditions had no effect on quality of life in children with myasthenia and advises reducing quality-of-life monitoring on that basis | A strong answer conveys: Quality-of-life scores in children with myasthenia showed no statistically significant difference between prepandemic and pandemic-era assessments; Daily-activity scores likewise showed no statistically significant difference between the two assessments; Both sets of scores shifted in the direc... | 10.1177/08830738251366857 | paywalled |
steered/10.1136/bmjno-2026-001556 | neuroimmunology | How do COVID-19 vaccine antibody responses relate to breakthrough infection and severe COVID-19 outcomes in people with MS on disease-modifying therapies? | [
"Anti-CD20 monoclonal antibody and sphingosine-1-phosphate receptor modulator therapy are associated with impaired vaccine antibody responses, with seroconversion frequently incomplete despite repeated doses",
"Antibody responses on other disease-modifying therapies are broadly comparable with those of healthy co... | The antibody findings rest on a large body of consistent observed comparisons, while the link between antibody status and clinical outcome is associative and the severe-outcome picture rests on very few events. | applies to COVID-19 vaccination in multiple sclerosis treated with disease-modifying therapy in adults sampled through a national registry-linked serology study, population-based settings | it presents antibody seroconversion as an established determinant of protection against severe disease, or recommends post-vaccination antibody testing to decide who needs additional vaccine doses or shielding | A strong answer conveys: Anti-CD20 monoclonal antibody and sphingosine-1-phosphate receptor modulator therapy are associated with impaired vaccine antibody responses, with seroconversion frequently incomplete despite repeated doses; Antibody responses on other disease-modifying therapies are broadly comparable with tho... | 10.1136/bmjno-2026-001556 | open |
steered/10.1136/archdischild-2025-330158 | sepsis | What have immunomodulator treatments shown in children with severe infection-related inflammatory syndromes? | [
"In children with sepsis-induced multiorgan dysfunction and immunoparalysis, randomised granulocyte-macrophage colony-stimulating factor treatment was stopped early because of a safety trend and low probability of efficacy",
"In children with septic shock, granulocyte-macrophage colony-stimulating factor was not ... | Evidence strength is uneven: the hyperinflammatory-syndrome effects come from controlled comparison of concurrently allocated treatment groups, whereas the colony-stimulating factor signals rest on a single uncontrolled clinical dataset and an investigation halted early whose findings remain unpublished. | applies to sepsis-induced multiorgan dysfunction and post-infectious hyperinflammatory syndrome in children, inpatient settings | it presents corticosteroids as proven to reduce mortality in children with septic shock or recommends steroids for every child with a hyperinflammatory phenotype on that basis | A strong answer conveys: In children with sepsis-induced multiorgan dysfunction and immunoparalysis, randomised granulocyte-macrophage colony-stimulating factor treatment was stopped early because of a safety trend and low probability of efficacy; In children with septic shock, granulocyte-macrophage colony-stimulating... | 10.1136/archdischild-2025-330158 | paywalled |
steered/10.1136/jnnp-2025-338335 | neuroimmunology | What is the spectrum and timing of psychiatric comorbidity relative to neurological onset in MOGAD? | [
"Depression, anxiety and attention-deficit/hyperactivity disorder are the psychiatric diagnoses most often documented in patients with MOGAD",
"A substantial share of patients acquire a new psychiatric diagnosis after neurological onset, although smaller published series have reported none",
"New psychiatric di... | Because the compared groups were matched rather than assigned and the diagnoses were drawn from clinical records compiled after the fact, the findings support temporal associations and documented patterns rather than causal effects, and smaller published accounts disagree on how often psychiatric illness is recorded. | applies to MOG antibody-associated disease in children and adults under specialist care, outpatient settings | it presents the post-onset clustering of psychiatric diagnoses as demonstrating MOG-IgG-mediated inflammation of limbic circuits or as a basis for escalating immunotherapy to treat mood symptoms | A strong answer conveys: Depression, anxiety and attention-deficit/hyperactivity disorder are the psychiatric diagnoses most often documented in patients with MOGAD; A substantial share of patients acquire a new psychiatric diagnosis after neurological onset, although smaller published series have reported none; New ps... | 10.1136/jnnp-2025-338335 | paywalled |
steered/10.1111/tan.70697 | neuroimmunology | What is known about HLA class I allele carriage and tacrolimus response in myasthenia gravis? | [
"HLA-C*03 carriage was more frequent among tacrolimus responders than non-responders in early-onset myasthenia gravis",
"HLA-C*03 carriage was also more frequent among responders when the initial tacrolimus blood concentration was higher",
"HLA-A*11:01 carriage was reported as a marker of poor tacrolimus respon... | These are preliminary subgroup observations from a single small treated sample, so directions are reported without dependable magnitude. | applies to myasthenia gravis treated with tacrolimus in Chinese adults, outpatient settings | it presents HLA typing as an established basis for selecting patients for, or withholding, tacrolimus in myasthenia gravis | A strong answer conveys: HLA-C*03 carriage was more frequent among tacrolimus responders than non-responders in early-onset myasthenia gravis; HLA-C*03 carriage was also more frequent among responders when the initial tacrolimus blood concentration was higher; HLA-A*11:01 carriage was reported as a marker of poor tacro... | 10.1111/tan.70697 | paywalled |
steered/10.1017/cjn.2025.10474 | neuroimmunology | How does autoantibody serostatus relate to visual recovery in severe optic neuritis without multiple sclerosis? | [
"MOG-IgG seropositivity is associated with the highest likelihood of good visual recovery in severe optic neuritis without multiple sclerosis",
"AQP4-IgG-positive and double-seronegative patients reached good visual recovery at several-fold lower rates than MOG-IgG-positive patients",
"AQP4-IgG-positive and dou... | The evidence is preliminary, resting on small numbers of patients within each antibody group, so serostatus differences in recovery are best read as associations rather than demonstrated effects, and the complete-recovery comparisons did not reach statistical significance. | applies to severe optic neuritis without multiple sclerosis in adults, outpatient settings | it presents antibody-guided escalation of acute immunotherapy, such as early plasma exchange, as demonstrated to improve visual recovery on this basis | A strong answer conveys: MOG-IgG seropositivity is associated with the highest likelihood of good visual recovery in severe optic neuritis without multiple sclerosis; AQP4-IgG-positive and double-seronegative patients reached good visual recovery at several-fold lower rates than MOG-IgG-positive patients; AQP4-IgG-posi... | 10.1017/cjn.2025.10474 | open |
steered/10.1177/10600280251406750 | sepsis | How do outcomes compare between hydrocortisone and vasopressin as the initial adjunct to norepinephrine in septic shock? | [
"Starting hydrocortisone rather than vasopressin as the first adjunct after norepinephrine is associated with lower in-hospital mortality",
"Patients started on vasopressin were more severely ill at the time the adjunct was begun",
"Because adjunct selection tracked severity of illness and local practice, confo... | The mortality comparison reflects an association seen in usual care between groups of unequal illness severity, and is hypothesis-generating rather than established. | applies to septic shock with escalating norepinephrine requirements in adults in mixed medical, surgical and cardiac intensive care, inpatient settings | it presents hydrocortisone-first adjunctive therapy as an established or causal mortality benefit over vasopressin, or recommends it as the preferred first adjunct on this basis | A strong answer conveys: Starting hydrocortisone rather than vasopressin as the first adjunct after norepinephrine is associated with lower in-hospital mortality; Patients started on vasopressin were more severely ill at the time the adjunct was begun; Because adjunct selection tracked severity of illness and local pra... | 10.1177/10600280251406750 | paywalled |
steered/10.1177/03000605261464273 | sepsis | How does regional citrate compare with heparin anticoagulation during CRRT for mortality in sepsis-associated acute kidney injury? | [
"Regional citrate anticoagulation is associated with lower 14- and 28-day mortality than systemic heparin in propensity-matched and covariate-adjusted analyses",
"Mortality by hospital discharge was numerically lower with citrate but did not differ significantly between the two anticoagulation strategies",
"Exp... | The short-term mortality difference rests on a modest adjusted association drawn from one small matched sample that still awaits external validation, and the subgroup contrasts remain hypothesis-generating. | applies to sepsis-associated acute kidney injury treated with continuous renal replacement therapy in critically ill adults, inpatient settings | it presents the survival advantage of citrate as an established or causal effect, or recommends citrate as the default anticoagulant on the basis of improved survival | A strong answer conveys: Regional citrate anticoagulation is associated with lower 14- and 28-day mortality than systemic heparin in propensity-matched and covariate-adjusted analyses; Mortality by hospital discharge was numerically lower with citrate but did not differ significantly between the two anticoagulation str... | 10.1177/03000605261464273 | open |
steered/10.17185/duepublico/85261 | neuroimmunology | How do stroke patients with pre-existing multiple sclerosis differ from stroke patients without multiple sclerosis? | [
"Stroke occurred at a younger age in patients with pre-existing multiple sclerosis, about ten years younger at the median than in patients without it",
"Arterial hypertension was the leading vascular risk factor in both groups, recorded at a similar frequency",
"In this single-centre series diabetes mellitus wa... | The evidence is weak and preliminary, resting on twenty-one affected patients from one hospital and unadjusted descriptive comparisons rather than on stable estimates. | applies to acute stroke in patients with pre-existing multiple sclerosis in adults, inpatient settings | it presents intravenous thrombolysis in multiple sclerosis as demonstrated to carry equivalent safety or benefit, or as shown to add no bleeding risk, on the basis of these few treated patients | A strong answer conveys: Stroke occurred at a younger age in patients with pre-existing multiple sclerosis, about ten years younger at the median than in patients without it; Arterial hypertension was the leading vascular risk factor in both groups, recorded at a similar frequency; In this single-centre series diabetes... | 10.17185/duepublico/85261 | open |
steered/10.1002/jmv.70840 | sepsis | What does detection of torque teno virus or herpesviruses by metagenomic sequencing indicate in critically ill patients with severe infection? | [
"Detection of torque teno virus or herpesvirus sequences by metagenomic sequencing was associated with roughly twice the odds of in-hospital major adverse events once illness severity was accounted for",
"Patients with viral detection had more secondary nosocomial infections and a rising incidence of major advers... | The association with in-hospital adverse events is a modest small-sample association rather than a demonstrated effect, and the immune-cell findings are preliminary. | applies to severe infection or sepsis in critically ill adults, inpatient settings | it recommends antiviral therapy or reduction of immunosuppressive drugs on the basis of viral detection, or presents such treatment as shown to lower adverse events | A strong answer conveys: Detection of torque teno virus or herpesvirus sequences by metagenomic sequencing was associated with roughly twice the odds of in-hospital major adverse events once illness severity was accounted for; Patients with viral detection had more secondary nosocomial infections and a rising incidence... | 10.1002/jmv.70840 | open |
steered/10.1177/20552076261422630 | sepsis | Which clinical and laboratory measurements at intensive care admission are associated with mortality in adults with sepsis? | [
"Among routinely collected admission measurements, the platelet distribution width to count ratio, mean platelet volume, serum creatinine, lactate, D-dimer, the APACHE II score and a respiratory source of infection were selected as related to 28-day mortality",
"Higher D-dimer, a higher APACHE II score and a resp... | The evidence is early and comes from a single centre without outside validation, so these admission measurements mark risk rather than proven causes. | applies to sepsis requiring intensive care admission in adults, inpatient settings | it presents the selected admission measurements as established causal drivers of death or recommends treatment aimed at correcting them on this basis | A strong answer conveys: Among routinely collected admission measurements, the platelet distribution width to count ratio, mean platelet volume, serum creatinine, lactate, D-dimer, the APACHE II score and a respiratory source of infection were selected as related to 28-day mortality; Higher D-dimer, a higher APACHE II ... | 10.1177/20552076261422630 | open |
steered/10.1002/mus.70135 | neuroimmunology | What is known about sex-related differences in efgartigimod efficacy in AChR-antibody-positive generalized myasthenia gravis? | [
"Responder proportions on the daily-living and quantitative myasthenia scales with efgartigimod versus placebo showed no significant difference between female and male patients",
"Quality-of-life improvement and attainment of minimal symptom expression favoured efgartigimod over placebo in both female and male pa... | The sex comparison rests on a small, post hoc subgroup split, so similar efficacy in women and men is suggestive rather than firmly established. | applies to acetylcholine receptor antibody-positive generalized myasthenia gravis in adults, outpatient settings | it presents similar efgartigimod efficacy in women and men as demonstrated equivalence, or uses it to rule out sex differences in response | A strong answer conveys: Responder proportions on the daily-living and quantitative myasthenia scales with efgartigimod versus placebo showed no significant difference between female and male patients; Quality-of-life improvement and attainment of minimal symptom expression favoured efgartigimod over placebo in both fe... | 10.1002/mus.70135 | open |
steered/10.1177/13524585261442036 | neuroimmunology | How does disease-modifying therapy efficacy class relate to progression independent of relapse and MRI activity in RRMS? | [
"Exposure to low-/moderate-efficacy disease-modifying therapy is associated with a several-fold higher hazard of progression independent of relapse and MRI activity than exposure to high-efficacy therapy",
"This pattern suggests that early progression independent of relapse and MRI activity remains at least partl... | The evidence is early and imprecise, resting on very few qualifying progression events in a single referral population, so the direction of the relationship is better supported than its size. | applies to relapsing-remitting multiple sclerosis in adults receiving disease-modifying therapy, outpatient settings | it presents higher-efficacy treatment as proven to prevent relapse-independent progression or recommends universal early escalation on this basis | A strong answer conveys: Exposure to low-/moderate-efficacy disease-modifying therapy is associated with a several-fold higher hazard of progression independent of relapse and MRI activity than exposure to high-efficacy therapy; This pattern suggests that early progression independent of relapse and MRI activity remain... | 10.1177/13524585261442036 | paywalled |
steered/10.1186/s41983-025-01053-5 | neuroimmunology | What outcomes are observed in patients with relapsing-remitting multiple sclerosis who receive ocrelizumab? | [
"Relapse activity declines during ocrelizumab treatment, with fewer patients relapsing and the median annualised relapse rate falling",
"Median disability scores on the Expanded Disability Status Scale improve from their pre-treatment values over the treatment year",
"Walking, hand-dexterity and processing-spee... | The evidence rests on early within-patient comparisons in a small group of patients over about a year of treatment, so it describes change during treatment rather than a demonstrated treatment effect. | applies to relapsing-remitting multiple sclerosis treated with ocrelizumab in adults, outpatient settings | it claims a reduction in overall brain and spinal cord lesion burden rather than in enhancing lesions alone | A strong answer conveys: Relapse activity declines during ocrelizumab treatment, with fewer patients relapsing and the median annualised relapse rate falling; Median disability scores on the Expanded Disability Status Scale improve from their pre-treatment values over the treatment year; Walking, hand-dexterity and pro... | 10.1186/s41983-025-01053-5 | open |
steered/10.1177/10962964261437315 | sepsis | What is known about corticosteroid prescribing for surgical intensive care patients with septic shock? | [
"Nearly all corticosteroid-treated patients received hydrocortisone",
"Fludrocortisone was added for only a small minority of treated patients",
"Among treated patients, initiation was divided close to evenly either side of 24 hours",
"Corticosteroids were dispensed to a minority of the surgical patients iden... | These are descriptive prescribing counts from record data, and the matched mortality and complication comparisons carry no effect estimates in this material, so no statement about benefit is supported. | applies to septic shock in adults managed in surgical intensive care, inpatient settings | it presents earlier corticosteroid initiation as causally improving survival in these patients, or mandates a fixed initiation deadline on that basis | A strong answer conveys: Nearly all corticosteroid-treated patients received hydrocortisone; Fludrocortisone was added for only a small minority of treated patients; Among treated patients, initiation was divided close to evenly either side of 24 hours; Corticosteroids were dispensed to a minority of the surgical patie... | 10.1177/10962964261437315 | paywalled |
steered/10.1007/s40120-025-00873-0 | neuroimmunology | How does oral corticosteroid dose change during complement C5 inhibitor compared with FcRn antagonist treatment in generalized myasthenia gravis? | [
"Over twelve months of continued therapy, oral corticosteroid average daily dose falls more with complement C5 inhibitor treatment than with FcRn antagonist treatment",
"Fewer patients remain on high daily corticosteroid doses at one year with complement C5 inhibition than with FcRn antagonist treatment",
"Beca... | The evidence is an observed difference between treatment groups that were not assigned, with a small comparison group, so it supports an association rather than a demonstrated advantage. | applies to generalized myasthenia gravis treated with an approved targeted biologic in insured adults taking oral corticosteroids, outpatient settings | it presents the greater corticosteroid dose reduction as a demonstrated causal advantage of complement C5 inhibition over FcRn antagonism, or recommends selecting one mechanism over the other on that basis | A strong answer conveys: Over twelve months of continued therapy, oral corticosteroid average daily dose falls more with complement C5 inhibitor treatment than with FcRn antagonist treatment; Fewer patients remain on high daily corticosteroid doses at one year with complement C5 inhibition than with FcRn antagonist tre... | 10.1007/s40120-025-00873-0 | open |
steered/10.1002/jbt.70673 | neuroimmunology | Which serum or cerebrospinal fluid biomarkers indicate dysregulation of the oxidative stress–neurosteroid axis in multiple sclerosis? | [
"Proposed indicators of dysregulation along the oxidative–neurosteroid axis include 8-hydroxydeoxyguanosine, the serum allopregnanolone-to-DHEA ratio and 3β-hydroxysteroid dehydrogenase enzymatic activity",
"These indicators are put forward as candidate markers of dysregulation rather than as measures with demons... | The paired oxidative–neurosteroid indicators are candidate measures supported so far by mechanistic reasoning and animal work, while the higher oxidative marker levels rest on comparisons with unaffected people and remain associations. | applies to multiple sclerosis in adults, outpatient settings | it recommends antioxidant plus neurosteroid treatment selected or monitored by these marker levels, whose supporting benefit data come from animal models | A strong answer conveys: Proposed indicators of dysregulation along the oxidative–neurosteroid axis include 8-hydroxydeoxyguanosine, the serum allopregnanolone-to-DHEA ratio and 3β-hydroxysteroid dehydrogenase enzymatic activity; These indicators are put forward as candidate markers of dysregulation rather than as meas... | 10.1002/jbt.70673 | paywalled |
steered/10.1002/mus.70177 | neuroimmunology | How does azathioprine compare with mycophenolate mofetil for reaching minimal manifestation status in acetylcholine receptor-positive generalized myasthenia gravis? | [
"Similar proportions of patients reach minimal manifestation status on azathioprine and on mycophenolate mofetil",
"Minimal manifestation status is reached sooner with mycophenolate mofetil than with azathioprine",
"On either drug, minimal manifestation status is typically reached only after many months of trea... | The evidence is a statistically balanced comparison of treatment as chosen in ordinary care, so the earlier attainment with mycophenolate mofetil is a reasonably supported association rather than an established superiority. | applies to acetylcholine receptor antibody-positive generalized myasthenia gravis in adults, outpatient settings | it presents mycophenolate mofetil as an established superior or better-tolerated option than azathioprine, or recommends switching or preferential prescribing on that basis | A strong answer conveys: Similar proportions of patients reach minimal manifestation status on azathioprine and on mycophenolate mofetil; Minimal manifestation status is reached sooner with mycophenolate mofetil than with azathioprine; On either drug, minimal manifestation status is typically reached only after many mo... | 10.1002/mus.70177 | paywalled |
steered/10.1002/mus.70242 | neuroimmunology | How do nerve ultrasound and nerve conduction features differ among typical, motor-predominant and pure motor CIDP? | [
"Upper limb nerve, cervical root and brachial plexus cross-sectional areas are larger in motor-predominant than in pure motor CIDP",
"Significant nerve enlargement was most frequent in typical CIDP, less frequent in motor-predominant disease and was observed in none of the few pure motor patients examined",
"De... | The graded pattern is an early observation from very small motor-variant groups with widely overlapping nerve sizes rather than an established distinction. | applies to chronic inflammatory demyelinating polyneuropathy including motor-predominant and pure motor variants in adults, outpatient settings | it asserts that nerve cross-sectional areas are significantly larger in typical than in motor-predominant CIDP, or that ultrasound reliably separates these two subtypes by nerve size | A strong answer conveys: Upper limb nerve, cervical root and brachial plexus cross-sectional areas are larger in motor-predominant than in pure motor CIDP; Significant nerve enlargement was most frequent in typical CIDP, less frequent in motor-predominant disease and was observed in none of the few pure motor patients ... | 10.1002/mus.70242 | paywalled |
steered/10.1002/ddr.70241 | sepsis | Which blood transcriptomic markers linked to lipopolysaccharide signaling distinguish septic patients from healthy controls? | [
"A lipopolysaccharide-responsive blood gene signature comprising S100A9, S100A12, IL1R2, GSTO1, UQCRH, LBH and SYNE2 separated septic patients from healthy controls with high reported accuracy across several expression datasets",
"S100A9 and S100A12 were markedly higher in septic blood, with IL1R2, GSTO1 and UQCR... | The evidence is preliminary and associative, since the reported separation of septic from healthy blood depends on previously archived public gene-expression data, and the direction of the expression differences was verified in only a very small number of participants. | applies to sepsis in adults, inpatient settings | it presents this gene panel as an established or clinically ready test for separating sepsis from other causes of critical illness, or recommends using it to make that distinction at the bedside | A strong answer conveys: A lipopolysaccharide-responsive blood gene signature comprising S100A9, S100A12, IL1R2, GSTO1, UQCRH, LBH and SYNE2 separated septic patients from healthy controls with high reported accuracy across several expression datasets; S100A9 and S100A12 were markedly higher in septic blood, with IL1R2... | 10.1002/ddr.70241 | paywalled |
steered/10.1177/17534666261459938 | sepsis | What factors are associated with death in immunocompromised patients with opportunistic pulmonary infections? | [
"Admission lymphopenia, seen as a lower lymphocyte count and a higher neutrophil-to-lymphocyte ratio, is associated with death within 28 days",
"A higher C-reactive protein at admission is associated with death within 28 days",
"Growth of multidrug-resistant bacteria is more frequent among patients who die than... | The supporting evidence establishes association rather than causation, and residual confounding may remain despite multivariable adjustment. | applies to opportunistic pulmonary infection during immunosuppressive therapy in adults, inpatient settings | it presents a high admission neutrophil count, lactate dehydrogenase or procalcitonin as an established predictor of death in these patients | A strong answer conveys: Admission lymphopenia, seen as a lower lymphocyte count and a higher neutrophil-to-lymphocyte ratio, is associated with death within 28 days; A higher C-reactive protein at admission is associated with death within 28 days; Growth of multidrug-resistant bacteria is more frequent among patients ... | 10.1177/17534666261459938 | open |
steered/10.1177/13524585251367343 | neuroimmunology | Which imaging features distinguish multiple sclerosis from AQP4-antibody NMOSD and MOGAD in suspected demyelinating syndromes? | [
"Brain lesion patterns typical of multiple sclerosis, such as lesions in the inferior temporal lobe and beside the lateral ventricle, Dawson's fingers, or U- or S-shaped juxtacortical lesions, favour established relapsing-remitting multiple sclerosis over AQP4-antibody NMOSD and MOGAD with high reported sensitivity... | The supporting evidence consists of descriptive imaging comparisons across antibody-defined patient groups, so these features shift diagnostic probability rather than confirm a diagnosis. | applies to suspected central nervous system demyelinating syndrome in adults and children, specialist neurology settings | it presents these imaging features as sufficient to establish or exclude MOGAD or AQP4-antibody NMOSD, or recommends forgoing antibody testing when the scan looks typical | A strong answer conveys: Brain lesion patterns typical of multiple sclerosis, such as lesions in the inferior temporal lobe and beside the lateral ventricle, Dawson's fingers, or U- or S-shaped juxtacortical lesions, favour established relapsing-remitting multiple sclerosis over AQP4-antibody NMOSD and MOGAD with high ... | 10.1177/13524585251367343 | paywalled |
steered/10.1002/jcp.70213 | sepsis | What is known about blood transcriptomic markers that separate adults with sepsis from healthy controls? | [
"Machine-learning feature selection on blood transcriptomic data identified TLR5, HMGB2 and C19orf59 as a candidate sepsis signature",
"Blood transcript levels of these three markers are higher in septic patients than in healthy controls",
"TLR5 and HMGB2 separate septic patients from controls best in those wit... | The evidence is early, resting mainly on previously collected public expression measurements alongside very small confirmatory experiments, so this marker panel is a promising lead rather than a demonstrated diagnostic test. | applies to sepsis in adults, inpatient settings | it presents this three-gene panel as a validated bedside test that can be used to diagnose sepsis or grade its severity | A strong answer conveys: Machine-learning feature selection on blood transcriptomic data identified TLR5, HMGB2 and C19orf59 as a candidate sepsis signature; Blood transcript levels of these three markers are higher in septic patients than in healthy controls; TLR5 and HMGB2 separate septic patients from controls best ... | 10.1002/jcp.70213 | paywalled |
steered/10.1007/s10791-026-09974-2 | sepsis | Which host blood gene expression signatures distinguish patients with sepsis from non-septic controls? | [
"In datasets not used for gene selection, a compact panel of immune-related blood genes including the calgranulins S100A8, S100A9 and S100A12 together with CD177, ARG1, GATA3 and SOCS3 separated sepsis samples from non-septic control samples with high discrimination",
"Classifiers built from the neutrophil-driven... | The supporting evidence is preliminary and computationally derived from archived blood expression datasets, holding consistently across several separately analysed sample sets but not tested during clinical care. | applies to sepsis in adults and children sampled during acute illness alongside healthy or non-infected comparison groups, mixed settings | it presents the gene panel as a clinically validated diagnostic test, recommends it in place of existing sepsis diagnostics, or uses it to justify withholding antimicrobial treatment | A strong answer conveys: In datasets not used for gene selection, a compact panel of immune-related blood genes including the calgranulins S100A8, S100A9 and S100A12 together with CD177, ARG1, GATA3 and SOCS3 separated sepsis samples from non-septic control samples with high discrimination; Classifiers built from the n... | 10.1007/s10791-026-09974-2 | open |
steered/10.1177/08927790251409715 | sepsis | How does time from emergency presentation to nephrostomy drainage relate to infectious outcomes in infected obstructing ureteral stones? | [
"Among patients drained soonest after arrival, the proportion with sepsis fell after nephrostomy insertion",
"The proportion in septic shock rose after insertion in the later-drained groups, whereas it was unchanged in the soonest-drained group",
"Patients drained soonest arrived with the most deranged physiolo... | The evidence supports associations only: the infectious rates before and after drainage were compared within each timing group without a comparison group, and the soonest-drained patients were the sickest on arrival. | applies to obstructing ureteral stone with urinary tract infection drained by percutaneous nephrostomy in adults, inpatient settings | it presents prompt drainage as demonstrated to cause the better outcomes, to prevent septic shock or to reduce mortality, or treats a fixed hour-based door-to-drainage threshold as an established standard on this basis | A strong answer conveys: Among patients drained soonest after arrival, the proportion with sepsis fell after nephrostomy insertion; The proportion in septic shock rose after insertion in the later-drained groups, whereas it was unchanged in the soonest-drained group; Patients drained soonest arrived with the most deran... | 10.1177/08927790251409715 | paywalled |
steered/10.1136/bmjoq-2026-004168 | sepsis | Which bedside scores stratify in-hospital mortality risk among emergency department patients with suspected sepsis receiving intravenous antibiotics? | [
"Scores that combine vital signs with routine admission blood results, the REDS score and its shortened qREDS variant, discriminated in-hospital mortality better than NEWS2 in adults given intravenous antibiotics for a suspected infection",
"At the upper score bands, specificity for in-hospital death was high for... | The evidence rests on previously recorded data from a single hospital comparing bedside scores, so it can rank mortality risk but cannot show that acting on a score changes outcome. | applies to suspected sepsis treated with intravenous antibiotics in adults, emergency department settings | it presents these scores as validated decision rules for triage or for withholding, delaying or de-escalating acute sepsis care in patients who score below a cut-off | A strong answer conveys: Scores that combine vital signs with routine admission blood results, the REDS score and its shortened qREDS variant, discriminated in-hospital mortality better than NEWS2 in adults given intravenous antibiotics for a suspected infection; At the upper score bands, specificity for in-hospital de... | 10.1136/bmjoq-2026-004168 | open |
steered/10.1186/s12883-025-04493-x | neuroimmunology | What phenotype characterizes patients with coexisting MOG antibody and anti-NMDAR antibody positivity? | [
"At onset these patients present with an encephalitis-spectrum picture in which fever, headache, altered consciousness, neuropsychiatric disturbance and seizures are the common features",
"Brain MRI is abnormal in roughly two thirds of patients, with supratentorial cortical and subcortical lesions predominating o... | The evidence is preliminary, resting on only a handful of dual-antibody-positive patients, so the phenotype should be regarded as an early description and the apparent differences from MOG antibody-associated disease as associations rather than established facts. | applies to coexisting MOG antibody and anti-NMDAR antibody positivity (antibody overlap syndrome) in children and adults, inpatient settings | it presents the fall in disability scores after acute immunotherapy as demonstrating treatment efficacy, or as showing that antibody overlap responds better to steroids plus immunoglobulin than single-antibody disease | A strong answer conveys: At onset these patients present with an encephalitis-spectrum picture in which fever, headache, altered consciousness, neuropsychiatric disturbance and seizures are the common features; Brain MRI is abnormal in roughly two thirds of patients, with supratentorial cortical and subcortical lesions... | 10.1186/s12883-025-04493-x | open |
steered/10.1007/s40120-026-00901-7 | neuroimmunology | What is known about starting cladribine tablets soon after natalizumab discontinuation in relapsing multiple sclerosis? | [
"Cladribine tablets started within about a month of the last natalizumab infusion were followed by relapse rates and MRI lesion activity that stayed as low as before the switch in uncontrolled observation",
"No new safety signals were reported after this rapid start in the small group observed",
"The switches o... | The switch observations are early and uncontrolled, drawn from a small low-activity group reported in abstract form without a comparison group, so they support feasibility rather than protection against rebound. | applies to relapsing multiple sclerosis treated with natalizumab in adults, outpatient settings | it presents the short interval to the first cladribine course as an established means of preventing rebound activity, or recommends it on that basis for patients with breakthrough disease activity while on natalizumab | A strong answer conveys: Cladribine tablets started within about a month of the last natalizumab infusion were followed by relapse rates and MRI lesion activity that stayed as low as before the switch in uncontrolled observation; No new safety signals were reported after this rapid start in the small group observed; Th... | 10.1007/s40120-026-00901-7 | open |
steered/10.1177/20503121261481481 | sepsis | How does lactated Ringer's exposure before sepsis diagnosis relate to mortality in critically ill adults? | [
"Lactated Ringer's exposure before sepsis diagnosis is associated with lower 28-day mortality than no exposure",
"In-hospital mortality is also lower with pre-diagnosis lactated Ringer's exposure than without exposure",
"The lower-mortality association persists after adjustment for elective surgery and total re... | The strength of this evidence supports an association only, because the mortality difference may reflect earlier recognition and resuscitation practice rather than the fluid itself. | applies to sepsis meeting Sepsis-3 criteria in critically ill adults, inpatient settings | it recommends pre-emptive lactated Ringer's infusion in patients not yet suspected of sepsis, or presents earlier fluid exposure as established grounds for changing resuscitation practice | A strong answer conveys: Lactated Ringer's exposure before sepsis diagnosis is associated with lower 28-day mortality than no exposure; In-hospital mortality is also lower with pre-diagnosis lactated Ringer's exposure than without exposure; The lower-mortality association persists after adjustment for elective surgery ... | 10.1177/20503121261481481 | open |
steered/10.1136/bmj-2024-081109 | neuroimmunology | What clinical features distinguish chronic inflammatory demyelinating polyneuropathy from diabetic polyneuropathy in people with diabetes? | [
"Proximal arm and leg weakness together with distal weakness, generalised areflexia extending to the upper limbs, rapidly progressive symptoms, early motor deficits and asymmetric findings point towards CIDP",
"Diabetic polyneuropathy by contrast is sensory predominant and slowly progressive, with little motor in... | These are described clinical patterns rather than features with measured discriminative accuracy, so they raise or lower suspicion but do not by themselves settle the diagnosis. | applies to suspected chronic inflammatory demyelinating polyneuropathy in the presence of diabetes in adults, outpatient settings | it presents demyelinating-range nerve conduction findings on their own as sufficient to establish CIDP in a person with diabetes, or recommends starting immunomodulatory treatment on that basis | A strong answer conveys: Proximal arm and leg weakness together with distal weakness, generalised areflexia extending to the upper limbs, rapidly progressive symptoms, early motor deficits and asymmetric findings point towards CIDP; Diabetic polyneuropathy by contrast is sensory predominant and slowly progressive, with... | 10.1136/bmj-2024-081109 | paywalled |
steered/10.1177/17562864261458528 | neuroimmunology | What outcomes have been observed in patients with MOGAD who receive ofatumumab as maintenance immunotherapy? | [
"No relapses were observed in patients while they were receiving ofatumumab over about a year of treatment",
"Disability scores improved from patients' own pre-treatment values during ofatumumab treatment",
"MRI lesion burden decreased from baseline, although lesions persisted in some treated patients",
"Gluc... | These are preliminary, uncontrolled observations in a small treated group compared with its own pre-treatment status over one year, so they suggest benefit rather than establish it. | applies to MOGAD in children and adults receiving maintenance immunotherapy, outpatient settings | it presents ofatumumab as established long-term relapse prevention in MOGAD or recommends it as first-line maintenance therapy on this basis | A strong answer conveys: No relapses were observed in patients while they were receiving ofatumumab over about a year of treatment; Disability scores improved from patients' own pre-treatment values during ofatumumab treatment; MRI lesion burden decreased from baseline, although lesions persisted in some treated patien... | 10.1177/17562864261458528 | open |
steered/10.1136/jnnp-2025-336773 | neuroimmunology | What is known about how intrathecal EBV-DNA detection relates to clinical and cerebrospinal fluid findings in GFAP astrocytopathy? | [
"Clinical symptoms, cerebrospinal fluid findings and MRI findings did not differ significantly between patients with and without intrathecal EBV-DNA detection",
"Individual neurological symptoms were numerically more frequent in patients with detectable intrathecal EBV-DNA, but no symptom comparison reached stati... | The evidence remains preliminary, since the small number of patients analysed leaves the comparisons underpowered to rule out modest differences. | applies to autoimmune GFAP astrocytopathy in adults, inpatient settings | it presents cerebrospinal fluid EBV viral load as an established prognostic marker or recommends guiding treatment decisions in autoimmune GFAP astrocytopathy on the basis of cerebrospinal fluid EBV-DNA results | A strong answer conveys: Clinical symptoms, cerebrospinal fluid findings and MRI findings did not differ significantly between patients with and without intrathecal EBV-DNA detection; Individual neurological symptoms were numerically more frequent in patients with detectable intrathecal EBV-DNA, but no symptom comparis... | 10.1136/jnnp-2025-336773 | paywalled |
steered/10.1111/ejh.70160 | immunology | How do outcomes with pirtobrutinib compare with ibrutinib in chronic lymphocytic leukemia without prior BTK inhibitor exposure? | [
"Pirtobrutinib achieved progression-free survival at least as good as ibrutinib in patients with no prior covalent BTK inhibitor exposure, a small difference consistent with non-inferiority rather than superiority",
"Overall response rates were numerically higher with pirtobrutinib than with ibrutinib but not sta... | Allocation to one drug or the other was made by a chance-based procedure, which supports the head-to-head comparison, yet the progression-free survival separation is small and assessed at an early time point, and the tolerability difference is presented without a formal statistical test of the contrast. | applies to chronic lymphocytic leukemia without prior covalent BTK inhibitor exposure in adults, outpatient settings | it presents an established long-term durability or survival advantage of noncovalent over covalent BTK inhibition, or recommends switching first-line therapy on this basis | A strong answer conveys: Pirtobrutinib achieved progression-free survival at least as good as ibrutinib in patients with no prior covalent BTK inhibitor exposure, a small difference consistent with non-inferiority rather than superiority; Overall response rates were numerically higher with pirtobrutinib than with ibrut... | 10.1111/ejh.70160 | paywalled |
steered/10.1177/09612033251414739 | immunology | What relationship do circulating interleukin-23 levels have with disease activity in systemic lupus erythematosus? | [
"Pooled data show a moderate positive correlation between circulating interleukin-23 and SLEDAI-measured disease activity, while individual reports range from a clear positive relationship to none, so the strength of this link is disputed",
"Interleukin-23 levels did not separate patients with active disease from... | Nothing was assigned, the pooled active-versus-inactive comparison was null, and sources disagree about the size of the activity link, so this remains a suggestive association rather than an established relationship. | applies to systemic lupus erythematosus in adults, mixed settings | it presents this cytokine as an established, ready-to-use marker for monitoring lupus activity or for selecting therapy, or treats its link with activity scores as evidence that it drives disease activity | A strong answer conveys: Pooled data show a moderate positive correlation between circulating interleukin-23 and SLEDAI-measured disease activity, while individual reports range from a clear positive relationship to none, so the strength of this link is disputed; Interleukin-23 levels did not separate patients with act... | 10.1177/09612033251414739 | paywalled |
steered/10.1177/09612033261469027 | immunology | What factors are associated with hydroxychloroquine-induced retinopathy in adults with systemic lupus erythematosus? | [
"Higher daily and higher weight-adjusted hydroxychloroquine doses are associated with hydroxychloroquine-induced retinopathy",
"Markers of active lupus such as proteinuria, and mycophenolate mofetil exposure, were less frequent rather than more frequent among patients with retinopathy, an unexpected inverse patte... | The reported relationships reflect statistical association rather than established causation, and the corticosteroid-timing and inverse-marker signals rest on only a small number of affected patients, so they remain tentative. | applies to systemic lupus erythematosus treated with hydroxychloroquine in adults, outpatient settings | it states that dosing at or below the recommended weight-based maximum removes retinopathy risk or that retinal screening can safely be deferred for the first five years of therapy | A strong answer conveys: Higher daily and higher weight-adjusted hydroxychloroquine doses are associated with hydroxychloroquine-induced retinopathy; Markers of active lupus such as proteinuria, and mycophenolate mofetil exposure, were less frequent rather than more frequent among patients with retinopathy, an unexpect... | 10.1177/09612033261469027 | paywalled |
steered/10.1002/cam4.72111 | immunology | How do ibrutinib, acalabrutinib, and zanubrutinib compare for atrial fibrillation risk in mantle cell lymphoma? | [
"Newly recorded atrial fibrillation or flutter is less frequent with acalabrutinib than with ibrutinib, on the order of a third as frequent",
"Newly recorded atrial fibrillation or flutter is likewise less frequent with zanubrutinib than with ibrutinib",
"Atrial fibrillation or flutter frequency is similar betw... | The claims rest on consistently observed associations rather than demonstrated causal effects, and residual confounding by baseline disease risk, line of therapy and treatment era leaves the magnitude of each difference uncertain. | applies to mantle cell lymphoma treated with a covalent Bruton tyrosine kinase inhibitor in adults, outpatient settings | it treats the lower atrial fibrillation frequency with second-generation agents as proof that ibrutinib causes atrial fibrillation or as grounds for switching every ibrutinib-treated patient | A strong answer conveys: Newly recorded atrial fibrillation or flutter is less frequent with acalabrutinib than with ibrutinib, on the order of a third as frequent; Newly recorded atrial fibrillation or flutter is likewise less frequent with zanubrutinib than with ibrutinib; Atrial fibrillation or flutter frequency is ... | 10.1002/cam4.72111 | open |
steered/10.1177/13591053251400827 | immunology | What psychological factors relate to distress in adults with autoimmune inflammatory rheumatic diseases? | [
"Higher ruminative thinking is associated with greater psychological distress",
"Greater perceived compassion from others is associated with lower psychological distress independently of the other psychological, clinical and demographic factors examined",
"Self-compassion's association with lower distress appea... | The evidence is preliminary and correlational, drawn from a small, narrowly recruited group of participants, so the direction of influence cannot be established, and whether self-compassion carries less weight than compassion received from others remains unresolved. | applies to autoimmune inflammatory rheumatic diseases (rheumatoid arthritis, psoriatic arthritis, axial spondyloarthritis) in adults, predominantly women in middle age, outpatient settings | it presents compassion-focused or rumination-targeted therapy as demonstrated to reduce anxiety and depression in inflammatory rheumatic disease, or recommends it on that basis as established care | A strong answer conveys: Higher ruminative thinking is associated with greater psychological distress; Greater perceived compassion from others is associated with lower psychological distress independently of the other psychological, clinical and demographic factors examined; Self-compassion's association with lower di... | 10.1177/13591053251400827 | paywalled |
steered/10.1136/rmdopen-2026-006825 | immunology | What is known about which patient characteristics accompany the choice of JAK inhibitors, IL-6 inhibitors or CTLA4-Ig in rheumatoid arthritis? | [
"JAK inhibitors are more often started in patients who lack features that would make them ineligible for the pivotal trials",
"IL-6 inhibitors and CTLA4-Ig are more often selected for patients with anaemia or organ dysfunction",
"Trial-ineligibility features are unevenly distributed across the biologic and targ... | The evidence is descriptive rather than comparative, drawn from prescribing as it occurred across several Japanese treatment sites, so it indicates how clinicians distribute patients across drug classes rather than how those classes perform in such patients, and allocation habits in other settings may differ. | applies to rheumatoid arthritis requiring biologic or targeted synthetic DMARD therapy in adults treated in Japanese specialist practice, outpatient settings | it presents IL-6 inhibitors or CTLA4-Ig as demonstrated to be more effective or safer than other classes in patients with anaemia or organ dysfunction, or recommends class selection on that basis as established | A strong answer conveys: JAK inhibitors are more often started in patients who lack features that would make them ineligible for the pivotal trials; IL-6 inhibitors and CTLA4-Ig are more often selected for patients with anaemia or organ dysfunction; Trial-ineligibility features are unevenly distributed across the biolo... | 10.1136/rmdopen-2026-006825 | open |
steered/10.1177/09612033251408937 | immunology | Which ocular manifestations occur in children with juvenile systemic lupus erythematosus on ophthalmologic screening? | [
"Dry eye abnormalities are the predominant finding on ophthalmologic examination, with a short tear film break-up time in most children and positive fluorescein staining in nearly half",
"Only a small minority of these children report dry eye symptoms, so the abnormalities are picked up on examination rather than... | These are single-examination observations from a small group of children without a comparison group, and the proportion classified as having dry eye depends on the criteria applied, so they should be treated as provisional. | applies to juvenile systemic lupus erythematosus in children and adolescents, outpatient settings | it presents these tear film and staining abnormalities as establishing secondary Sjögren's syndrome in most affected children or recommends starting treatment for that diagnosis on this basis | A strong answer conveys: Dry eye abnormalities are the predominant finding on ophthalmologic examination, with a short tear film break-up time in most children and positive fluorescein staining in nearly half; Only a small minority of these children report dry eye symptoms, so the abnormalities are picked up on examina... | 10.1177/09612033251408937 | paywalled |
steered/10.1002/hon.70229 | immunology | What outcomes follow allogeneic stem cell transplantation in high-risk chronic lymphocytic leukaemia? | [
"Most patients are alive and free of progression two years after transplantation",
"Survival free of graft-versus-host disease and relapse is clearly lower than overall survival",
"Acute and chronic graft-versus-host disease each develop in a substantial proportion of transplanted patients",
"Late relapses af... | The supporting evidence comes from one small, mixed group of transplant recipients that also encompassed Richter transformation, so the outcome estimates should be treated as provisional rather than established. | applies to high-risk or heavily pretreated chronic lymphocytic leukaemia treated with allogeneic stem cell transplantation in adults, inpatient settings | it presents post-transplant cyclophosphamide or post-transplant ibrutinib as an established means of reducing graft-versus-host disease, or recommends either on that basis | A strong answer conveys: Most patients are alive and free of progression two years after transplantation; Survival free of graft-versus-host disease and relapse is clearly lower than overall survival; Acute and chronic graft-versus-host disease each develop in a substantial proportion of transplanted patients; Late rel... | 10.1002/hon.70229 | paywalled |
steered/10.1136/rmdopen-2026-006934 | immunology | How well do clinical screening criteria detect interstitial lung disease in rheumatoid arthritis? | [
"Criteria combining risk factors, persistent respiratory symptoms and auscultation behave as a rule-out rather than a confirmatory test, with high sensitivity and negative predictive value but low specificity and positive predictive value, so a positive screen needs imaging confirmation",
"Items based only on res... | The evidence is a descriptive single-visit account of how the screening criteria behave against chest imaging in routine specialist practice, adequate for ruling disease out but not for showing that the rule anticipates disease appearing later, and component-level performance rests on few disease cases. | applies to rheumatoid arthritis without previously diagnosed interstitial lung disease in adults in routine specialist care, outpatient settings | it presents longer disease duration, diagnostic delay or higher inflammatory activity as established characteristics that should drive screening decisions on this evidence | A strong answer conveys: Criteria combining risk factors, persistent respiratory symptoms and auscultation behave as a rule-out rather than a confirmatory test, with high sensitivity and negative predictive value but low specificity and positive predictive value, so a positive screen needs imaging confirmation; Items b... | 10.1136/rmdopen-2026-006934 | open |
steered/10.1177/03000605261444928 | immunology | Which neuroimaging patterns are described in patients with neuropsychiatric systemic lupus erythematosus? | [
"Microhaemorrhage was the most commonly recorded brain parenchymal abnormality",
"Haemorrhagic and ischaemic infarcts were each recorded in fewer patients than microhaemorrhage",
"Arterial imaging showed a beaded appearance of the middle cerebral artery or its branches in a minority of patients",
"Venous imag... | Because the supporting evidence comes from a small, uncontrolled group of hospitalised patients with no comparison group, the reported patterns should be read as illustrative of what may occur rather than as established frequencies. | applies to neuropsychiatric systemic lupus erythematosus in young adults, predominantly women, inpatient settings | it presents a beaded angiographic appearance as an established or specific diagnostic marker of cerebral vasculitis in lupus, or recommends withholding immunosuppressive treatment when angiography appears normal | A strong answer conveys: Microhaemorrhage was the most commonly recorded brain parenchymal abnormality; Haemorrhagic and ischaemic infarcts were each recorded in fewer patients than microhaemorrhage; Arterial imaging showed a beaded appearance of the middle cerebral artery or its branches in a minority of patients; Ven... | 10.1177/03000605261444928 | open |
steered/10.1136/rmdopen-2024-004310 | immunology | What is known about emerging treatments for systemic disease activity in Sjögren's disease? | [
"Dual BAFF/APRIL blockade with telitacicept reduced systemic disease activity scores compared with placebo in randomised trials conducted in China",
"FcRn-directed IgG lowering with nipocalimab or efgartigimod met its primary endpoint in early randomised testing",
"Patient-reported dryness, fatigue and pain imp... | Support is firmest for dual BAFF/APRIL blockade, yet it rests entirely on evidence gathered within a single country, whereas the other agents have been assessed only at a preliminary stage, where disease heterogeneity, small participant numbers and sizeable placebo responses constrain interpretation. | applies to primary Sjögren's disease with systemic disease activity in adults, outpatient settings | it presents any of these targeted agents as established or approved therapy for systemic Sjögren's disease, or recommends adopting one in routine care or for preventing long-term organ damage on this basis | A strong answer conveys: Dual BAFF/APRIL blockade with telitacicept reduced systemic disease activity scores compared with placebo in randomised trials conducted in China; FcRn-directed IgG lowering with nipocalimab or efgartigimod met its primary endpoint in early randomised testing; Patient-reported dryness, fatigue ... | 10.1136/rmdopen-2024-004310 | open |
steered/10.1002/ajh.70331 | immunology | Which quality-of-life domains remain impaired in Hodgkin lymphoma survivors compared with the general population? | [
"Overall and physical health-related quality of life is lower in people treated for Hodgkin lymphoma than in age- and sex-matched general-population comparators, by margins that are modest in size yet clinically important",
"Fatigue and dyspnea are the symptom domains that differ most from comparators",
"The lo... | The pattern is consistent across several validated measures in a large matched comparison, but it reflects associations measured at a single point in time rather than demonstrated causes of the impairment, and modest, unbalanced survey response leaves room for residual confounding. | applies to Hodgkin lymphoma after completion of treatment in adults across a wide age range, outpatient settings | it presents treatment-related cardiopulmonary toxicity as the demonstrated cause of the reduced quality of life, or recommends routine cardiac and pulmonary surveillance of all survivors on that basis | A strong answer conveys: Overall and physical health-related quality of life is lower in people treated for Hodgkin lymphoma than in age- and sex-matched general-population comparators, by margins that are modest in size yet clinically important; Fatigue and dyspnea are the symptom domains that differ most from compara... | 10.1002/ajh.70331 | open |
steered/10.1177/09612033261435924 | immunology | What is known about immunosuppressive management of shrinking lung syndrome in systemic lupus erythematosus? | [
"Reported management pairs corticosteroids with a steroid-sparing immunosuppressive agent, most often rituximab",
"A substantial share of reported patients received high-dose corticosteroid monotherapy instead of a steroid-sparing agent",
"Pulmonary function improved in roughly half of the patients who were tre... | The supporting evidence comes from a handful of individually described patients treated without any comparison group or head-to-head comparison of agents, with heterogeneous and often incomplete follow-up, so the findings describe observed patterns of care and recovery rather than established treatment effects. | applies to shrinking lung syndrome complicating systemic lupus erythematosus in adults, predominantly women, outpatient settings | it presents rituximab, or any other agent, as an established first-line therapy of proven superiority, or prescribes a standardised regimen on this basis | A strong answer conveys: Reported management pairs corticosteroids with a steroid-sparing immunosuppressive agent, most often rituximab; A substantial share of reported patients received high-dose corticosteroid monotherapy instead of a steroid-sparing agent; Pulmonary function improved in roughly half of the patients ... | 10.1177/09612033261435924 | paywalled |
steered/10.1177/1759720x261462685 | immunology | How do multiple chronic conditions relate to health outcomes in adults with autoimmune and inflammatory rheumatic diseases? | [
"A greater burden of coexisting chronic conditions is associated with increased all-cause mortality and shorter survival",
"A greater burden of coexisting chronic conditions is associated with worsening disability, poorer functional status and lower health-related quality of life",
"A greater burden of coexisti... | The direction of the outcome associations holds across most of the diseases considered, yet the supporting evidence establishes association rather than demonstrated causation, the mortality pattern is not uniform, and the survival and disability models leave their sample size and specific disease population unstated. | applies to autoimmune and inflammatory rheumatic diseases in adults, outpatient settings | it presents multidisciplinary, deprescribing or self-management programmes as demonstrated to improve survival, function or quality of life in adults with these diseases and multiple chronic conditions, or recommends them on that basis | A strong answer conveys: A greater burden of coexisting chronic conditions is associated with increased all-cause mortality and shorter survival; A greater burden of coexisting chronic conditions is associated with worsening disability, poorer functional status and lower health-related quality of life; A greater burden... | 10.1177/1759720x261462685 | open |
steered/10.1002/hon.70235 | immunology | What is the treatment outcome for combining duvelisib and oral azacitidine in patients with relapsed or refractory mature T-cell lymphoma? | [
"Duvelisib combined with oral azacitidine produced objective responses in roughly half of evaluable patients, most of those responses being complete",
"Complete responses were enriched in the T-follicular-helper phenotype, a preliminary observation resting on very few such patients",
"Median progression-free su... | The evidence is early, uncontrolled and rests on very few treated patients with heavily censored time-to-event data, so it points to encouraging activity rather than established benefit. | applies to relapsed or refractory mature T-cell lymphoma in adults, outpatient settings | it presents the combination as demonstrated to be superior to single-agent therapy or recommends it as standard treatment or a routine bridge to transplant on this basis | A strong answer conveys: Duvelisib combined with oral azacitidine produced objective responses in roughly half of evaluable patients, most of those responses being complete; Complete responses were enriched in the T-follicular-helper phenotype, a preliminary observation resting on very few such patients; Median progres... | 10.1002/hon.70235 | paywalled |
steered/10.1002/ajh.70293 | immunology | How do pretreatment serum soluble TNFR2 levels relate to survival in newly diagnosed lymphoma? | [
"Higher pretreatment serum sTNFR2 is associated with inferior overall survival, consistently across the major Hodgkin and non-Hodgkin subtypes",
"Patients in the highest sTNFR2 group carry a few-fold higher risk of death than those in the lowest group",
"The survival association persists after accounting for ag... | The direction of the association between higher receptor levels and shorter survival holds across subtypes and persists after adjustment, yet it rests on a single pretreatment measurement in one patient group whose grouping cut-points were derived from those same participants, without standardised assay thresholds or c... | applies to newly diagnosed Hodgkin and non-Hodgkin lymphoma in adults, outpatient settings | it treats sTNFR2 as a validated treatment-selection tool, directing therapy escalation, de-escalation or receptor-targeted treatment by a patient's measured level | A strong answer conveys: Higher pretreatment serum sTNFR2 is associated with inferior overall survival, consistently across the major Hodgkin and non-Hodgkin subtypes; Patients in the highest sTNFR2 group carry a few-fold higher risk of death than those in the lowest group; The survival association persists after accou... | 10.1002/ajh.70293 | open |
steered/10.1177/20406207261474934 | immunology | What are the treatment outcomes with novel targeted therapies such as BTK inhibitors or BCL2 inhibitors in CLL with CNS involvement? | [
"Most reported treatment courses with targeted agents produced a documented CNS response (roughly nine in ten), with complete resolution of CNS disease in over half of the courses",
"Reported toxicity was infrequent and in keeping with the known safety profiles of the agents used",
"Ibrutinib was the agent used... | These are pooled case-level observations without any comparison group, so the response and safety patterns are suggestive rather than established. | applies to central nervous system involvement by CLL/SLL in adults, mixed settings | it presents one targeted regimen as demonstrated to be superior to another or to chemotherapy-based treatment, or endorses a specific agent as standard therapy on this basis | A strong answer conveys: Most reported treatment courses with targeted agents produced a documented CNS response (roughly nine in ten), with complete resolution of CNS disease in over half of the courses; Reported toxicity was infrequent and in keeping with the known safety profiles of the agents used; Ibrutinib was th... | 10.1177/20406207261474934 | open |
steered/10.1002/ajh.70317 | immunology | What outcomes follow checkpoint inhibitor therapy in relapsed or refractory primary mediastinal B-cell lymphoma? | [
"Salvage checkpoint inhibitor therapy produced overall responses in around two thirds of patients and complete responses in about half",
"Complete responses were durable, with no relapses recorded among complete responders followed over several years",
"Most patients were still alive several years after startin... | The evidence is early and uncontrolled, drawn from patients whose treating physicians selected the regimen without allocation by chance, so it characterises observed response, survival and safety patterns rather than establishing that one regimen causes better outcomes than another. | applies to relapsed or refractory primary mediastinal B-cell lymphoma in adults, outpatient settings | it presents nivolumab plus brentuximab vedotin as a proven superior regimen to pembrolizumab or recommends preferring it as standard salvage on this evidence | A strong answer conveys: Salvage checkpoint inhibitor therapy produced overall responses in around two thirds of patients and complete responses in about half; Complete responses were durable, with no relapses recorded among complete responders followed over several years; Most patients were still alive several years a... | 10.1002/ajh.70317 | paywalled |
steered/10.1002/ajh.70225 | immunology | What outcomes follow fixed-duration subcutaneous mosunetuzumab in relapsed/refractory follicular lymphoma after two or more prior therapies? | [
"Fixed-duration subcutaneous mosunetuzumab produced complete remission in roughly three in five heavily pretreated patients",
"Complete remissions were durable, with median duration beyond two years",
"Freedom from progression lasted a median of close to two years",
"Cytokine release syndrome occurred less of... | The remission and remission-duration figures come from a modest, uncontrolled treated group and the comparison between routes rests on groups that were not assigned by chance, so the evidence supports consistency rather than a proven advantage of one route. | applies to relapsed or refractory follicular lymphoma after two or more prior systemic therapies in adults, outpatient settings | it presents the lower cytokine release syndrome rate as proof that subcutaneous dosing is the safer route overall, or recommends subcutaneous over intravenous administration on that basis, rather than reporting it as a signal from a comparison that was not assigned by chance | A strong answer conveys: Fixed-duration subcutaneous mosunetuzumab produced complete remission in roughly three in five heavily pretreated patients; Complete remissions were durable, with median duration beyond two years; Freedom from progression lasted a median of close to two years; Cytokine release syndrome occurred... | 10.1002/ajh.70225 | open |
steered/10.1002/hon.70221 | immunology | What is the economic value of adding epcoritamab to lenalidomide plus rituximab in relapsed or refractory follicular lymphoma for US payers? | [
"Adding epcoritamab to lenalidomide plus rituximab was projected to increase quality-adjusted life expectancy at substantially higher total cost",
"The resulting incremental cost per quality-adjusted life-year gained fell below the willingness-to-pay threshold usually applied by US payers",
"The acquisition cos... | The estimates are early projections built on borrowed cost and quality-of-life inputs and extrapolated survival, and they hold below conventional thresholds across the parameter ranges and most alternative assumptions tested, so they indicate likely economic value rather than measured experience. | applies to relapsed or refractory follicular lymphoma after at least one prior line of therapy in adults, population-based settings | it presents the added agent as cost-saving or cost-neutral through avoided progression care, or treats the projected survival gain as an observed benefit that establishes preferred payer coverage | A strong answer conveys: Adding epcoritamab to lenalidomide plus rituximab was projected to increase quality-adjusted life expectancy at substantially higher total cost; The resulting incremental cost per quality-adjusted life-year gained fell below the willingness-to-pay threshold usually applied by US payers; The acq... | 10.1002/hon.70221 | paywalled |
Subsets and Splits
No community queries yet
The top public SQL queries from the community will appear here once available.